Ampleia
Created in 2023
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
406Entity types
Location
1 Rue de l'internationale, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 2-10
Estimated: 6
SIREN
949162317Engaged corporates
6
1 5Added in Motherbase
5 months, 2 weeks ago
Incubators & VCs Value proposition
Drive the exceptional
Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
Biotechnologies, Rare diseases, Lifesciences, and InvestmentsOriginal language
Drive the exceptional
Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects. We work with exceptional scientists and entrepreneurs developing therapeutic options for under-served indications. We act as an operating co-founder from day 1, bringing funding, translational development capabilities and corporate support. We are from each decision to prepare the founders and the company to Series A or strategic deal. We adopt a technology-agnostic approach and work on projects from anywhere in the world.
Ampleia, a venture-builder for rare diseases
Ampleia is a venture builder dedicated to rare diseases. We support therapeutic research projects to create company and ensure translational development.
https://www.ampleia.eu/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other | ||
 | PariSanté Campus | Other 31 Aug 2023 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 30 Apr 2023 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 19 Apr 2024 | | |
 Takeda Pharmaceutical, Pharmaceutical Manufacturing | Takeda Pharmaceutical, Pharmaceutical Manufacturing | Other 14 Dec 2023 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 30 Apr 2023 | | |
 | Aquitaine Science Transfert (SATT Aquitaine) | Other 28 Nov 2023 | | |